Related Experiment Videos
Graves' ophthalmopathy
1Department of Internal Medicine, Naval Hospital, Long Beach, California 90822.
The Western Journal of Medicine
|June 1, 1993
Summary
Graves' disease can cause ophthalmopathy in 30% of patients, leading to various eye issues. While often benign and improving over time, severe cases may require treatments like corticosteroids, radiation, or surgery.
Area of Science:
- Endocrinology
- Ophthalmology
- Immunology
Background:
- Graves' disease affects approximately 30% of patients with Graves' disease, an autoimmune disorder.
- The underlying cause is likely autoimmune, similar to hyperthyroidism.
- Ophthalmopathy presents with diverse symptoms including lid lag, swelling, proptosis, and potentially vision-threatening conditions like optic neuropathy.
Purpose of the Study:
- To summarize the key aspects of Graves' ophthalmopathy.
- To outline the typical disease course and available treatment modalities.
Main Methods:
- Review of existing literature on Graves' ophthalmopathy.
- Analysis of common clinical manifestations and natural history.
- Evaluation of therapeutic interventions.
Main Results:
- Ophthalmopathy occurs in about 30% of Graves' disease patients.
- The condition is typically benign, with 90% experiencing gradual improvement.
- Symptoms range from cosmetic (lid lag, swelling) to functional (diplopia, optic neuropathy).
Conclusions:
- Graves' ophthalmopathy is a common autoimmune complication of Graves' disease.
- Most cases resolve spontaneously, but severe or disfiguring cases necessitate intervention.
- Treatment options include corticosteroids, radiation, and surgery, with surgery often preferred for severe presentations.